Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4 Lymphoma, Follicular 4 Lymphoma 4 Infections 4 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Waldenstrom Macroglobulinemia 2 Thyroid Nodule 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neutropenia 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Intraocular Lymphoma 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Febrile Neutropenia 2 Burkitt Lymphoma 2 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Surgical Wound Infection 1 Sepsis 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Nitrofurantoin 1 Linezolid 1 Fluconazole 1 Ciprofloxacin 1 Cefuroxime 1 Amoxicillin-Potassium Clavulanate Combination 1 Amoxicillin 1 Amdinocillin Pivoxil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cystectomy × Amoxicillin-Potassium Clavulanate Combination × Clear all

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting

Cystectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡